NJTC Venture Fund
Tech Council Ventures (TCV) is a venture firm that invests in early-stage technology companies in the Mid-Atlantic region. With $175M assets under management, the firm provides Seed and Series A financing (typical check sizes $500K–$3M) and offers portfolio support through its network aligned with TechUnited/technology council resources.
Industries
Nr. of Employees
small (1-50)
Portfolio
Recognized on CB Insights Digital Health 150 (2022); featured in Penn Medicine press release; CEO Subha Airan-Javia received a Sharp Index Award.
#Digital health / care coordination
Attained SOC 2 Type 2 compliance; ranked on the Inc. 5000 list (No.1 among private software companies in 2022); recipient of industry awards.
#Software / data analytics for pharmacy benefits
Received a $1.67M NIH NIAMS Phase II SBIR grant to develop a disease-modifying osteoarthritis drug.
#Biopharmaceuticals / therapeutics
Announced investment from Tech Council Ventures; later merged with Upgraid to expand position in clinical nutrition.
#Clinical nutrition / Food-as-Medicine
Featured in coverage of printed thin-film battery research and prototype testing.
#Energy / printed batteries / IoT
Recognized on CB Insights Digital Health 150 (2022); featured in Penn Medicine press release; CEO Subha Airan-Javia received a Sharp Index Award.
#Digital health / care coordination
Attained SOC 2 Type 2 compliance; ranked on the Inc. 5000 list (No.1 among private software companies in 2022); recipient of industry awards.
#Software / data analytics for pharmacy benefits
Received a $1.67M NIH NIAMS Phase II SBIR grant to develop a disease-modifying osteoarthritis drug.
#Biopharmaceuticals / therapeutics
Announced investment from Tech Council Ventures; later merged with Upgraid to expand position in clinical nutrition.
#Clinical nutrition / Food-as-Medicine
Featured in coverage of printed thin-film battery research and prototype testing.
#Energy / printed batteries / IoT